Papers/PMID:27333187
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
PloS one2016The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
all-cis-5,8,11,14,17-icosapentaenoic acid — accumulates in liver
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“The amount of hepatic EPA of AHF + EPA group was increased 3.9- and 29-fold in comparison with the chow and AHF groups, respectively.”
Quoted verbatim from Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.. - Study
- animal · not in humans
- Duration
- 4 weeks
- Dose
- EPA ethyl ester (95% grade) at 5% of the atherogenic high-fat diet, 4 weeks
- Population
- Male C57BL/6J mice fed an atherogenic high-fat diet supplemented with 5% EPA for four weeks, compared with chow and atherogenic high-fat diet alone
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.2016PMID:27333187Industry fundedPermalink